Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017040

Chief Operations Officer acquired 37,715 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2021-03-01 Grant or award +37,715 143,384 D
Derivatives
Newell Joe Chief Operations Officer 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +56,929 56,929 D
Loading xslF345X03/doc4.xml…